[HTML][HTML] Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets

LE Ferris, CD Naylor - CMAJ, 2004 - Can Med Assoc
Principle 11:“It is acceptable for physicians to receive remuneration for enrolling patients or
participating in approved research studies only if such activity exceeds their normal practice …

Commentary: per capita payments in clinical trials: reasonable costs versus bounty hunting

MA Hall, JY Friedman, NMP King, KP Weinfurt… - Academic …, 2010 - journals.lww.com
Paying more for clinical research than the cost of doing the work may create a conflict of
interest that could lead to overzealous recruitment, putting participants and scientific integrity …

Making or losing money with participation in clinical trials: a decision analysis

VR Jacobs - Oncology Research and Treatment, 2009 - karger.com
Background: There is increasing demand and qualitydriven pressure from professional
organizations for physicians and health care providers to increase participation in clinical …

Payer funding of interventional pharmacoeconomic studies: a new paradigm

DA Goldstein, AS Lichter, MJ Ratain - Health Affairs Forefront, 2019 - healthaffairs.org
The high cost of pharmaceuticals has provided the stimulus for a new research discipline:
interventional pharmacoeconomics. In this discipline, clinical and pharmacological …

[HTML][HTML] Clinical trial remuneration: the patients' perspective

LJ Burgess, N Sulzer, S Emanuel - SAMJ: South African Medical …, 2008 - scielo.org.za
Clinical trial remuneration: The patients' perspective SciELO - Scientific Electronic Library
Online vol.98 issue2 author index subject index articles search Home Page alphabetic serial …

Clinical trials: considerations for researchers and hospital administrators

O Uecke, R Reszka, J Linke, M Steul… - Health care …, 2008 - journals.lww.com
Background: Clinical studies play a pivotal role in the development of new pharmaceutical
drugs. Before newly developed active substances can be put on the market, the law requires …

[HTML][HTML] Randomized clinical trials: slow death by a thousand unnecessary policies?

S Yusuf - Cmaj, 2004 - Can Med Assoc
Viewpoint fees were paid to centres for each patient recruited. These fees became
increasingly larger as companies “competed” to conduct trials. Second, the attitudes of …

Estimating per patient funding for cancer clinical trials: An Ontario based survey

JR Wright, K Roche, B Smuck, J Cormier… - Contemporary clinical …, 2005 - Elsevier
The financial implications of conducting clinical trials in oncology have not been well
researched from a perspective that would facilitate the negotiation of appropriate …

The impact of managed care on clinical research

M McKee, E Mossialos - Pharmacoeconomics, 1998 - Springer
Traditionally, US teaching hospitals have subsidised research by charging higher costs for
treatment; however, this approach is being challenged. The growth of managed-care …

Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study

J Raftery, J Bryant, J Powell, C Kerr… - Health Technology …, 2008 - wrap.warwick.ac.uk
Objectives: To review UK guidelines regarding the use of financial incentives for healthcare
professionals to become involved in clinical trials, and to survey perceptions and current …